General Information
Roche DM2 BP29476
A Multi-center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase 2A Study with an Open-Label Active Group to Assess the Efficacy and Safety of Once-Daily RO6811135 in Type 2 Diabetic Patients Inadequately Controlled with Metformin.
| Protocol | BP29476 |
|---|---|
| Identifier | BP29476 Site Number: 281536 |
| UID | 52fb7844-8120-415d-a7fc-875851e8833b |
| Status | Done - Archived |
| Phase | 2A |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2015 |
| NCT Number | - |
| Created | 2015-03-17 12:29 |
| Last Updated | 2015-03-17 12:29 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2015-04-20 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-02-25 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Roche |
|---|---|
| Division | Roche |
| Team | Roche |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | 4773-016W |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
